Aqlivia

Almere, Netherlands Founded: 2019 • Age: 7 yrs
Delivers comprehensive services in regulatory affairs, clinical trials, monitoring, and data management.
Annual revenue $11,365 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Aqlivia

Aqlivia is a company based in Almere (Netherlands) founded in 2019. It operates as a B2B. Aqlivia operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.

  • Headquarter Almere, Netherlands
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Aqlivia Private Limited
  • Date of Incorporation 27 Aug, 2019
  • Jurisdiction Bangalore, Karnataka, India
Operational Areas
Healthcare → Healthcare Education, Research & Associations Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $11.37 K (USD)
    -87.97
    as on Mar 31, 2023
  • Net Profit
    -$3.83 K (USD)
    -236.11
    as on Mar 31, 2023
  • EBITDA
    -$4.01 K (USD)
    -424.85
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Aqlivia

Premium access

Detailed funding history for Aqlivia

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aqlivia

Investments
Premium access

Investment portfolio details for Aqlivia

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Aqlivia

Premium access

Detailed financials for Aqlivia

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Aqlivia Comparisons

Aqlivia Primary company
Description
Delivers comprehensive services in regulatory affairs, clini...
Location
Almere, Netherlands
Founded Year
2019
Annual Revenue
$11.37 K (USD)
Net Profit
-$3.83 K (USD)
EBITDA
-$4.01 K (USD)
Employees
Not available
Premium access

Peer comparison for Aqlivia

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Aqlivia

Aqlivia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of CRO and CDMO services
Locked Locked Locked
Laboratory testing and contract research services are provided globally.
Locked Locked Locked
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
Locked Locked Locked
Branded and generic prescription drugs are developed, manufactured, and marketed.
Locked Locked Locked
Advisory, scientific, and medical communications provided for pharmaceutical industry.
Locked Locked Locked
Regulatory support, brand differentiation, and prototyping services are provided.
Premium access

Detailed competitors of Aqlivia

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Aqlivia

Premium access

Complete news archive for Aqlivia

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aqlivia

Aqlivia was founded in 2019.

Aqlivia is headquartered in Almere, Netherlands. It is registered at Almere, Flevoland, Netherlands.

Annual revenue of Aqlivia is $11.37K as on Mar 31, 2023.

Aqlivia, established in 2019, excels in providing healthcare solutions, life sciences, clinical trials, and regulatory services. Delivers comprehensive services in regulatory affairs, clinical trials, monitoring, and data management. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Aqlivia's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available